{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:18:43Z","timestamp":1793841523332,"version":"4.6.1"},"reference-count":135,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaip.2024.06.010","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T09:00:52Z","timestamp":1718269252000},"page":"2310-2324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Type 2 Inflammation and Asthma in Children: A Narrative Review"],"prefix":"10.1016","volume":"12","author":[{"given":"Nikolaos G.","family":"Papadopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Bacharier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Deschildre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Phipatanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Szefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ledanois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juby A.","family":"Jacob-Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.06.010_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5588\/ijtld.22.1010","article-title":"The Global Asthma Report 2022","volume":"26","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jaip.2024.06.010_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03179-2021","article-title":"Asthma management in low and middle income countries: case for change","volume":"60","author":"Mortimer","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.iac.2014.09.006","article-title":"Inner city asthma","volume":"35","author":"Gergen","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.06.010_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaip.2017.04.031","article-title":"Severe asthma in children","volume":"5","author":"Ramratnam","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S2213-2600(20)30399-4","article-title":"Advances in understanding and reducing the burden of severe asthma in children","volume":"8","author":"Pijnenburg","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fped.2019.00256","article-title":"Asthma in children and adults\u2014what are the differences and what can they tell us about asthma?","volume":"7","author":"Trivedi","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2024.06.010_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fped.2018.00186","article-title":"The burden of pediatric asthma","volume":"6","author":"Ferrante","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2024.06.010_bib9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1398-9995.2012.02865.x","article-title":"International consensus on (ICON) pediatric asthma","volume":"67","author":"Papadopoulos","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/ped.2018.0886","article-title":"Asthma endotyping and biomarkers in childhood asthma","volume":"31","author":"Licari","year":"2018","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1016\/j.jaip.2024.06.010_bib11","first-page":"187","article-title":"Evolution of airway inflammation in preschoolers with asthma\u2014results of a two-year longitudinal study","volume":"9","author":"Xepapadaki","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaip.2014.06.022","article-title":"Severe asthma in children","volume":"2","author":"Guilbert","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib13","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2016.09.028","article-title":"Individualized therapy for persistent asthma in young children","volume":"138","author":"Fitzpatrick","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/ppul.24176","article-title":"Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: a systematic review","volume":"53","author":"Castro-Rodriguez","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2024.06.010_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/17476348.2023.2254234","article-title":"Severe pediatric asthma endotypes: current limits and future perspectives","volume":"17","author":"Andrenacci","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamapediatrics.2017.3579","article-title":"Association between inhaled corticosteroid and bone fracture in children with asthma","volume":"172","author":"Gray","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2024.06.010_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamapediatrics.2021.0433","article-title":"Association of oral corticosteroid bursts with severe adverse events in children","volume":"175","author":"Yao","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2024.06.010_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaci.2022.08.014","article-title":"Determinants of lung function across childhood in the Severe Asthma Research Program (SARP) 3","volume":"151","author":"Gaffin","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib19","doi-asserted-by":"crossref","first-page":"00576","DOI":"10.1183\/23120541.00576-2021","article-title":"Type 2 inflammation in asthma and other airway diseases","volume":"8","author":"Maspero","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2024.06.010_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.jaip.2020.12.027","article-title":"Factors associated with asthma severity in children: data from the French COBRAPed cohort","volume":"9","author":"Lezmi","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01633-2019","article-title":"Clinical utility of fractional exhaled nitric oxide (FeNO) in severe asthma management","volume":"55","author":"Menzies-Gow","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S2213-2600(21)00124-7","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis","volume":"9","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2023.09.044","article-title":"Blood eosinophil and FeNO are prognostic and predictive biomarkers in childhood asthma","volume":"154","author":"Bacharier","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.06.010_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40348-023-00159-1","article-title":"Childhood asthma phenotypes and endotypes: a glance into the mosaic","volume":"10","author":"Foppiano","year":"2023","journal-title":"Mol Cell Pediatr"},{"key":"10.1016\/j.jaip.2024.06.010_bib26","article-title":"Cytokine profile in childhood asthma","volume":"91","author":"Matysiak","year":"2022","journal-title":"J\u00a0Med Sci"},{"key":"10.1016\/j.jaip.2024.06.010_bib27","first-page":"3","article-title":"Molecular endotypes of pediatric asthma: a novel language directs asthma treatment! Egypt","volume":"14","author":"Shaheen","year":"2016","journal-title":"J\u00a0Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.23736\/S0026-4806.21.07332-8","article-title":"Asthma phenotypes and endotypes in childhood","volume":"113","author":"Fainardi","year":"2022","journal-title":"Minerva Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib29","first-page":"1329","article-title":"Atopic and non-atopic asthma phenotypes in children","volume":"37","author":"Aycin","year":"2021","journal-title":"Acta Med Mediterr"},{"key":"10.1016\/j.jaip.2024.06.010_bib30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaci.2016.06.059","article-title":"Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents","volume":"138","author":"Pongracic","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227091","article-title":"A\u00a0modern approach to identifying and characterizing child asthma and wheeze phenotypes based on clinical data","volume":"14","author":"Brew","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.06.010_bib32","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2021.02.040","article-title":"Endotype of allergic asthma with airway obstruction in urban children","volume":"148","author":"Altman","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1183\/13993003.00284-2015","article-title":"Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis","volume":"47","author":"Garden","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2014present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaip.2024.06.010_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cyto.2015.05.019","article-title":"Mast cell production and response to IL-4 and IL-13","volume":"75","author":"McLeod","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaip.2024.06.010_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.06.010_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7835284","article-title":"The role of T cells and macrophages in asthma pathogenesis: a new perspective on mutual crosstalk","volume":"2020","author":"Zhu","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaip.2024.06.010_bib41","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nri2870","article-title":"Functions of T cells in asthma: more than just TH2 cells","volume":"10","author":"Lloyd","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib42","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1183\/13993003.00947-2016","article-title":"Mast cells are associated with exacerbations and eosinophilia in children with severe asthma","volume":"48","author":"Lezmi","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1183\/09031936.00123411","article-title":"Two novel, severe asthma phenotypes identified during childhood using a clustering approach","volume":"40","author":"Just","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/pai.13268","article-title":"Severe preschool asthmatics have altered cytokine and anti-viral responses during exacerbation","volume":"31","author":"Lejeune","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"Gandhi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib47","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jaip.2018.05.010","article-title":"Eosinophilic esophagitis is a late manifestation of the allergic march","volume":"6","author":"Hill","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib48","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3389\/fimmu.2020.01907","article-title":"Research progress in atopic march","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001748","article-title":"Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies","volume":"11","author":"Belgrave","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib51","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1164\/rccm.202110-2418OC","article-title":"Evolution of eczema, wheeze, and rhinitis from infancy to early adulthood: four birth cohort studies","volume":"206","author":"Haider","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI Biologicals Guidelines\u2014recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.alit.2020.02.005","article-title":"Japanese guidelines for childhood asthma 2020","volume":"69","author":"Arakawa","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2024.06.010_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European Respiratory Society\/American Thoracic Society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib57","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/all.13561","article-title":"Provocative proposal for a revised nomenclature for allergy and other hypersensitivity diseases","volume":"73","author":"Ring","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib58","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03393-2020","article-title":"Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation","volume":"58","author":"Busse","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib59","first-page":"1165","article-title":"Barrier impairment and type 2 inflammation in allergic diseases: the pediatric perspective","volume":"8","author":"Ghezzi","year":"2021","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jaip.2024.06.010_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.962693","article-title":"Role of airway epithelial cell miRNAs in asthma","volume":"3","author":"Boateng","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2563","article-title":"Allergy: mechanistic insights into new methods of prevention and therapy","volume":"15","author":"Akdis","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib62","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/all.15240","article-title":"Epithelial barrier hypothesis: effect of the external exposome on the microbiome and epithelial barriers in allergic disease","volume":"77","author":"Celebi","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib63","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.jaip.2021.02.059","article-title":"Cluster analysis of inflammatory biomarker expression in the International Severe Asthma Registry","volume":"9","author":"Denton","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114046","article-title":"Childhood asthma heterogeneity at the era of precision medicine: modulating the immune response or the microbiota for the management of asthma attack","volume":"179","author":"Lejeune","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaip.2024.06.010_bib65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.iac.2018.12.005","article-title":"The effects of the environment on asthma disease activity","volume":"39","author":"Louisias","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.06.010_bib66","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jaci.2016.08.046","article-title":"Latent class analysis reveals clinically relevant atopy phenotypes in 2 birth cohorts","volume":"139","author":"Hose","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib67","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.jaip.2021.02.007","article-title":"Characterization of asthma trajectories from infancy to young adulthood","volume":"9","author":"\u00d6dling","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaci.2016.03.049","article-title":"Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence","volume":"139","author":"Rubner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib69","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.200907-1101OC","article-title":"Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study","volume":"181","author":"Simpson","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib70","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/17476348.2015.1068693","article-title":"The need to differentiate between adults and children when treating severe asthma","volume":"9","author":"Fainardi","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib71","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2020.02.031","article-title":"Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthma","volume":"146","author":"Roberts","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2021.758719","article-title":"Performance of three asthma predictive tools in a cohort of infants hospitalized with severe bronchiolitis","volume":"2","author":"Fabiano Filho","year":"2021","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib73","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2016.06.061","article-title":"Asthma phenotypes in inner-city children","volume":"138","author":"Zoratti","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib74","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaip.2018.06.026","article-title":"Recurrent wheeze phenotypes in poor urban preschool-age children","volume":"7","author":"Reddy","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib75","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1164\/rccm.201609-1966OC","article-title":"Preventing severe asthma exacerbations in children. A randomized trial of mite-impermeable bedcovers","volume":"196","author":"Murray","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib76","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaip.2021.09.042","article-title":"of the Outdoor Mould ANSES Working Group. Outdoor mold and respiratory health: state of science of epidemiological studies","volume":"10","author":"Caillaud","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib77","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/all.15724","article-title":"Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?","volume":"78","author":"Annesi-Maesano","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib78","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMoa032097","article-title":"Results of a home-based environmental intervention among urban children with asthma","volume":"351","author":"Morgan","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib79","first-page":"19","article-title":"Objective immunological and clinical data observed during an altitude cure at Brian\u00e7on in asthmatic children allergic to house dust and dermatophagoides [in French]","volume":"7","author":"Vervloet","year":"1979","journal-title":"Rev Fr Mal Respir"},{"key":"10.1016\/j.jaip.2024.06.010_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/allergies3020009","article-title":"Genetic and epigenetic factors in risk and susceptibility for childhood asthma","volume":"3","author":"Miteva","year":"2023","journal-title":"Allergies"},{"key":"10.1016\/j.jaip.2024.06.010_bib81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng.2830","article-title":"A\u00a0genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations","volume":"46","author":"B\u00f8nnelykke","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2024.06.010_bib82","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1164\/rccm.201708-1762OC","article-title":"Cytokine responses to rhinovirus and development of asthma, allergic sensitization, and respiratory infections during childhood","volume":"197","author":"Custovic","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib83","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41590-019-0347-8","article-title":"Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children","volume":"20","author":"Altman","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41533-023-00330-1","article-title":"Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update","volume":"33","author":"Levy","year":"2023","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib85","article-title":"Utility of biomarkers in the diagnosis and monitoring of asthmatic children","volume":"16","author":"Xepapadaki","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.06.010_bib86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.chest.2018.10.009","article-title":"Change in FEV1 and FeNO measurements as predictors of future asthma outcomes in children","volume":"155","author":"Fielding","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2024.06.010_bib87","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MCP.0000000000000633","article-title":"Precision medicine in severe pediatric asthma: opportunities and challenges","volume":"26","author":"Vijverberg","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaci.2012.10.033","article-title":"Assessment of airflow limitation, airway inflammation, and symptoms during virus-induced wheezing episodes in 4- to 6-year-old children","volume":"131","author":"Konstantinou","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib89","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S2213-2600(21)00486-0","article-title":"Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial","volume":"10","author":"Turner","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib90","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12325-019-01191-2","article-title":"Ability of serum IgE concentration to predict exacerbation risk and benralizumab efficacy for patients with severe eosinophilic asthma","volume":"37","author":"Jackson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2024.06.010_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.rmed.2019.06.004","article-title":"Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility","volume":"154","author":"Humbert","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib92","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.125.4.1378","article-title":"Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma","volume":"125","author":"Bousquet","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2024.06.010_bib93","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1183\/13993003.01824-2014","article-title":"Asthma phenotypes and IgE responses","volume":"47","author":"Froidure","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib94","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1183\/09031936.00149812","article-title":"Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey","volume":"42","author":"Deschildre","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib95","first-page":"120","article-title":"Relationship between serum total IgE and disease severity in patients with allergic asthma in Spain","volume":"25","author":"Davila","year":"2015","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib96","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cea.13373","article-title":"Asthma with multiple allergic comorbidities is associated with complete response to omalizumab","volume":"49","author":"Ses\u00e9","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib97","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jaci.2020.01.021","article-title":"Serum IL-6: a biomarker in childhood asthma?","volume":"145","author":"Jackson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib98","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaip.2017.05.032","article-title":"Baseline features of the severe asthma research program (SARP III) cohort: differences with age","author":"Teague","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib99","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13880","article-title":"Grass pollen exposure is associated with higher readmission rates for pediatric asthma","volume":"33","author":"Batra","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib100","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaci.2020.02.001","article-title":"Toward personalization of asthma treatment according to trigger factors","volume":"145","author":"Niespodziana","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib101","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ccm.2018.10.010","article-title":"Asthma and corticosteroid responses in childhood and adult asthma","volume":"40","author":"Ramadan","year":"2019","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib102","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01011-2023","article-title":"Best step-up treatments for children with uncontrolled asthma: a systematic review and network meta-analysis of individual participant data","author":"Cividini","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib110","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2021.7872","article-title":"Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma: a systematic review and meta-analysis","volume":"325","author":"Kim","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.06.010_bib111","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.anai.2021.12.020","article-title":"Understanding the role of long-acting muscarinic antagonists in asthma treatment","volume":"128","author":"Muiser","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib112","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2017.01.014","article-title":"A\u00a0phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma","volume":"140","author":"Szefler","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib113","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jaip.2019.03.019","article-title":"Tiotropium is efficacious in 6- to 17-year-olds with asthma, independent of T2 phenotype","volume":"7","author":"Szefler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.010_bib114","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1542\/peds.108.2.e36","article-title":"Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)","volume":"108","author":"Milgrom","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2024.06.010_bib115","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2009.09.021","article-title":"Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma","volume":"124","author":"Lanier","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib116","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib117","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations","volume":"136","author":"Teach","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib118","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/all.13678","article-title":"Omalizumab discontinuation in children with severe allergic asthma: an observational real-life study","volume":"74","author":"Deschildre","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib119","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.aller.2018.09.009","article-title":"\u2018Real-life\u2019 experience in asthmatic children treated with omalizumab up to six-years follow-up","volume":"47","author":"Folqu\u00e9","year":"2019","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2024.06.010_bib120","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/pai.13484","article-title":"Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma","volume":"32","author":"Nieto Garc\u00eda","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib121","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03130-2021","article-title":"Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients","volume":"60","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.06.010_bib122","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201701-0120OC","article-title":"Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma","volume":"196","author":"Esquivel","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib123","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1164\/rccm.201606-1145LE","article-title":"Omalizumab is associated with reduced acute severity of rhinovirus-triggered asthma exacerbation","volume":"194","author":"Kantor","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib124","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2019.08.005","article-title":"Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype","volume":"144","author":"Gupta","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(22)01198-9","article-title":"Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"400","author":"Jackson","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.06.010_bib126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib127","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40264-020-00926-3","article-title":"Safety of eosinophil-depleting therapy for severe, eosinophilic asthma: focus on benralizumab","volume":"43","author":"Jackson","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2024.06.010_bib128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaci.2023.01.002","article-title":"Biologics in the treatment of asthma in children and adolescents","volume":"151","author":"Bacharier","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib129","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanizedanti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib130","doi-asserted-by":"crossref","DOI":"10.1111\/pai.14092","article-title":"Benralizumab in children with severe eosinophilic asthma: pharmacokinetics and long-term safety (TATE study)","volume":"35","author":"Wedner","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib131","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.06.010_bib132","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.06.010_bib133","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1073\/pnas.1323896111","article-title":"Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes","volume":"111","author":"Macdonald","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2024.06.010_bib134","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1073\/pnas.1324022111","article-title":"Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice","volume":"111","author":"Murphy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2024.06.010_bib135","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib136","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","article-title":"Dupilumab in children with uncontrolled moderate-to-severe asthma","volume":"385","author":"Bacharier","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.06.010_bib137","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/all.15743","article-title":"Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma","volume":"78","author":"Papadopoulos","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib138","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1080\/02770903.2023.2185895","article-title":"Dupilumab long-term efficacy in patients with non-OCS-dependent asthma with and without evidence of allergic asthma","volume":"60","author":"Sher","year":"2023","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2024.06.010_bib139","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2213-2600(23)00303-X","article-title":"Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study","volume":"12","author":"Bacharier","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"suppl 27","key":"10.1016\/j.jaip.2024.06.010_bib140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/pai.13622","article-title":"Safety of allergen-specific immunotherapy in children","volume":"33","author":"De Filippo","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib141","article-title":"Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies\u2014report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce","volume":"13","author":"Asllani","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib142","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI Guidelines on Allergen Immunotherapy: house dust mite-driven allergic asthma","volume":"74","author":"Agache","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.010_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106228","article-title":"Preventing asthma in high risk kids (PARK) with omalizumab: design, rationale, methods, lessons learned and adaptation","volume":"100","author":"Phipatanakul","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jaip.2024.06.010_bib144","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fimmu.2019.00821","article-title":"Mast cells and their progenitors in allergic asthma","volume":"10","author":"M\u00e9ndez-Enr\u00edquez","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.06.010_bib145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/TCRM.S170979","article-title":"Preschool children with persistent asthmatic symptoms","volume":"15","author":"Vogelberg","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jaip.2024.06.010_bib146","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa1513737","article-title":"Patterns of growth and decline in lung function in persistent childhood asthma","volume":"374","author":"McGeachie","year":"2016","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824006342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824006342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:29:01Z","timestamp":1730521741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824006342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":135,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213219824006342"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.06.010","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 Inflammation and Asthma in Children: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}